Rajnikant Mehta

Rajnikant Mehta is a Senior Clinical Trials Statistician at Queen Mary University of London, affiliated with the Wolfson Institute of Population Health and Barts Clinical Trials Unit. He holds a BSc (Hons) in Mathematics, Statistics, and Computing from the University of Greenwich, an MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine, and a Postgraduate Certificate in Academic Practice from the University of Southampton. With over 25 years of expertise, he has contributed to medical statistics, clinical trial design, and epidemiology across institutions including MRC Clinical Research Centre, GlaxoSmithKline, and multiple UK universities.

His research focuses on optimizing clinical trial methodologies (e.g., cluster RCTs, stepped-wedge designs) and improving patient outcomes in areas like pain management and surgical trials. He has supported NIHR grant applications and collaborated with multidisciplinary teams to design fundable clinical trials. His work emphasizes methodological rigor and translational research to address public health challenges.

Rajnikant’s publications span surgical outcomes, pain management innovations, and systematic reviews in specialties like ophthalmology and neurology. He has contributed to guideline development and quality improvement initiatives in primary care, emphasizing patient safety and avoidable harm reduction. His career includes academic teaching roles and leadership in clinical trial units across the UK.